Similarly, among patients in the MSI or not-assigned groups with an intermediate prognosis, those falling within the MPS3 subgroup exhibited a shorter recurrence duration, although the difference did not reach statistical significance ( Figure S2 E).
← all excerpts
Metabolism pathway-based subtyping in endometrial cancer: An integrated study by multi-omics analysis and machine learning algorithms.
1
—
—